Brief: BeyondSpring Reports Year End 2022 Financial Results
18/04/2023 21:39
April 18 (Reuters) - Beyondspring Inc BYSI.O :
* BEYONDSPRING PROVIDES BUSINESS UPDATE AND REPORTS YEAR END
2022
FINANCIAL RESULTS
* BEYONDSPRING INC - AS OF DECEMBER 31, 2022, HAD CASH, CASH
EQUIVALENTS, AND SHORT-TERM INVESTMENTS OF $37.3 MILLION
* BEYONDSPRING - CONTINUES TO MAKE PROGRESS IN ADVANCING
LEAD DRUG
CANDIDATE, PLINABULIN, AS 'PIPELINE IN A DRUG' ON REGULATORY
FRONT IN U.S., CHINA
Source text for Eikon: ID:nGNX1xdsDX
Further company coverage: BYSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beyondspring
See all newsBrief: Beyondspring Inc Entered Into Open Market Sale Agreement Under Which Co May Offer And Sell Up To 9.2 Million Ordinary Shares
Brief: Beyondspring Announces FDA Fast Track Designation For Plinabulin In Post-Ici Non-Squamous Nsclc And Strategic Transaction To Advance Global Phase 3 Dublin-4 Trial Toward Planned Interim Analysis
NASDAQ RESUMED AT 12:26 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:21 PM
Brief: Beyondspring Announces Leadership Transition To Deliver Focused Execution On Its Confirmatory Dublin-4 Program And Long-Term Value